Professional Documents
Culture Documents
INTRODUCTION
Insulinoma merupakan tumor yang diperoleh dari sel beta
pankreas.
Case
report
Pasien : wanita , 67 th
Hasil Pemeriksaan:
GCS = 9 dengan tanda vital dalam batas normal
Kadar glukosa : 8mmol/L.
Depresi
Osteoporosis
Hipertensi (-)
Hiperparatiroid (-)
Pemeriksaan
Pasien sadar namun terlihat sangat gelisah
Pemeriksaan Penunjang
CT scan abdomen
Pemeriksaan penunjang
Ultrasound guided liver biopsi
Ocreotide Scintigrafi
Menunjukan uptake yang kuat di pankreas dan hati tanpa
adanya lesi lebih lanjut.
Penatalaksanaan
Dextrosa intravena
Oral diaxozide
Subcutaneos ocreotide
Penatalaksanaan yang diberikan ternyata tidak
memberikan perubahan yang berarti pada simptom
hipoglikemia yang diderita pasien. Pemberian Ocreotide
cukup berespon pada hipoglikemia pasien, tetapi pasien
malah mengalami edema perifer dan abdominal cramp.
Penatalaksanaan lanjut
Pembedahan (laparotomi)
Distal pankreotomi
Splenektomi
Hepatektomi kanan
Diskusi
Insulinoma adalah insulin secreting tumor dari beta sel
pankreas, 80 % pasien ddiagnosa dengan tumor yang
kecil dan jinak
- Lokalisasi tumor
- Metastatis tumor
Diskusi
Terapi medika mentosa pada insulinoma di indikasikan
untuk pasien yang sulit mengontrol hipoglikemia
sambil menunggu terapi definitif yang lebih lanjut.
Kesimpulan
Insulinoma dengan metastatik pada pasien diabetes
merupakan penyakit yang sangat sangat jarang.
Referensi
[3] R. Brentjens and L. Saltz, Islet cell tumors of the pancreas: the medical oncologists
perspective, Surgical Clinics of North America, vol. 81, no. 3, pp. 527542, 2001.
[5] G. Rindi, G. Klo ppel, H. Alhman et al., TNM staging of foregut (neuro)endocrine
tumors: a consensus proposal including a grading system, Virchows Archiv, vol. 449, no.
4, pp. 395401, 2006.
[6] C. Toyoda, K. Hosokawa, Y. Atsumi et al., Malignant insuli- noma with extensive liver
metastases presenting as disturbance of consciousness , Internal Medicine, vol. 37, no. 5, pp.
476 479, 1998.
[7] M. Alison, Endoscopic ultrasound in the detection of pan- creatic islet cell tumours, Cancer
Imaging, vol. 4, pp. 8491, 2004.
[9] D. Vezzosi, A. Bennet, P. Rochaix et al., Octreotide in insuli- noma patients: efficacy on
hypoglycemia, relationships with Octreoscan scintigraphy and immunostaining with anti-sst2A
and anti-sst5 antibodies, European Journal of Endocrinology, vol. 152, no. 5, pp. 757767,
2005.
11] J.Bertherat,F.Tenenbaum,K.Perlemoineetal.,Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas:
an in vivo and in vitro study, Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 11, pp. 53535360, 2003.
[12] W. Y. Lei, T. E. Wang, T. L. Chen, W. H. Chang, T. L. Yang, and C. Y. Wang, Insulinoma causing hypoglycemia in a patient with
type 2 diabetes, Journal of the Formosan Medical Association, vol. 106, no. 5, pp. 392396, 2007.
[13] L. A. Kane, C. S. Grant, T. B. Nippoldt, and F. J. Service, Insulinoma in a patient with NIDDM, Diabetes Care, vol. 16, no. 9, pp.
12981300, 1993.
[14] H. Ishii, T. Ito, S. Moriya, Y. Horie, and M. Tsuchiya, Insulinomaa statistical review of 443 cases in Japan, Nippon Rinsho, vol.
51, supplement, pp. 199206, 1993.
[15] B. E. Stabile, Islet cell tumors, Gastroenterologist, vol. 5, no. 3, pp. 213232, 1997.
[16] G.V.Gill,O.Rauf,andI.A.MacFarlane,Diazoxidetreatment for insulinoma: a national UK survey, Postgraduate Medical Journal, vol.
73, no. 864, pp. 640641, 1997.
[17] L. Moscetti, R. Saltarelli, R. Giuliani, G. Fornarini, M. Bezzi, and E. Cortesi, Intra-arterial liver chemotherapy and hormone therapy
in malignant insulinoma: case report and review of the literature, Tumori, vol. 86, no. 6, pp. 475479, 2000.
[18] M. H. Kulke, E. K. Bergsland, and J. C. Yao, Glycemic control in patients with insulinoma treated
with everolimus, The New England Journal of Medicine, vol. 360, no. 2, pp. 195197, 2009.
[20] H. Liu, S.-Z. Zhang, Y.-L. Wu et al., Diagnosis and surgical treatment of pancreatic endocrine
tumors in 36 patients: a single-center report, Chinese Medical Journal, vol. 120, no. 17, pp. 14871490,
2007.
[21] R. Kianmanesh, A. Sauvanet, O. Hentic et al., Two-step surgery for synchronous bilobar liver
metastases from diges- tive endocrine tumors: a safe approach for radical resection, Annals of Surgery,
vol. 247, no. 4, pp. 659665, 2008.
[22] D. N. Danforth Jr., P. Gorden, and M. F. Brennan, Metastatic insulin-secreting carcinoma of the
pancreas: clinical course and the role of surgery, Surgery, vol. 96, no. 6, pp. 10271036,
1984.
[23] A. Begu-Le Corroller, R. Valero, V. Moutardier et al., Aggressive multimodal therapy of sporadic malignant insulinoma can
improve survival: a retrospective 35-year study of 12 patients,
Diabetes and Metabolism, vol. 34, no. 4, pp. 343348, 2008.
[24] D. J. Kwekkeboom, J. J. Teunissen, W. H. Bakker et al., Radiolabeled somatostatin analog [177Lu-DOTA0, Tyr3]octreotate in
patients with endocrine gastroenteropancreatic tumors, Journal of
Clinical Oncology, vol. 23, no. 12, pp. 27542762, 2005.